Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue Suppl 2
631 Phase I dose escalation study in patients with advanced solid tumors with ANV419, a novel fusion protein selective for IL-2Rβ/γ
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
631 Phase I dose escalation study in patients with advanced solid tumors with ANV419, a novel fusion protein selective for IL-2Rβ/γ
Free
Online download statistics by month:
Online download statistics by month: November 2022 to August 2024
Abstract
Full
Pdf
Nov 2022
210
0
15
Dec 2022
36
0
4
Jan 2023
36
0
8
Feb 2023
62
0
3
Mar 2023
30
0
6
Apr 2023
50
0
9
May 2023
42
0
8
Jun 2023
26
0
2
Jul 2023
26
0
1
Aug 2023
28
0
5
Sep 2023
20
0
5
Oct 2023
18
0
2
Nov 2023
40
0
3
Dec 2023
32
0
4
Jan 2024
14
0
1
Feb 2024
8
0
1
Mar 2024
24
0
6
Apr 2024
40
0
3
May 2024
22
0
1
Jun 2024
18
0
4
Jul 2024
46
0
3
Aug 2024
24
0
4
Total
852
0
98
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?